RxDoctor Payments Data

John Elders, MD

Family Medicine · Mountain Home, ARNPI 1174520688

Payments from drug & device makers

$1,803in general payments, 2019–2025

Across 111 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$448
  • Pfizer$213
  • GSK$187
  • AbbVie$174
  • Abbott$129
  • Astellas Pharma US Inc$111
  • plus $541 from 16 others

What the payments were for

  • Food & beverage$1,803100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,803 in reported general payments places this provider in the 70th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$451,001
Medicare patients
905
Services billed
8,517

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban183$125,951
OzempicSemaglutide32$36,039
JardianceEmpagliflozin33$30,230
ArexvyRsvpref3 Antigen/As01e/Pf83$26,868
JanuviaSitagliptin Phosphate26$17,219
XareltoRivaroxaban27$16,658
ShingrixVaricella-Zoster Ge/As01b/Pf73$16,505
FarxigaDapagliflozin Propanediol21$12,895
TrulicityDulaglutide12$11,720
MyrbetriqMirabegron50$11,441
Humalog Kwikpen U-100Insulin Lispro16$8,596
KerendiaFinerenone12$7,527
SymbicortBudesonide/Formoterol Fumarate14$6,639
Atorvastatin Calcium695$6,361
V-Go 40Sub-Q Insulin Device, 40 Unit12$6,071

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$213$131,496194 claims
GSKArexvy, Shingrix$187$43,373156 claims
Novo NordiskOzempic$15$36,03932 claims
Boehringer IngelheimJardiance$53$30,23033 claims
AstraZenecaFarxiga, Symbicort$15$19,53435 claims
MerckJanuvia$75$17,21926 claims
Johnson & JohnsonXarelto$56$16,65827 claims
Lilly USA, LLCTrulicity$31$11,72012 claims
Astellas Pharma US IncMyrbetriq$111$11,44150 claims
BayerKerendia$74$7,52712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Mountain Home

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →